Ascentage Pharma Group International (AAPG) Accounts Payables: 2023-2024
- Ascentage Pharma Group International's Accounts Payables rose 25.22% to $12.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $12.6 million, marking a year-over-year increase of 25.22%. This contributed to the annual value of $12.6 million for FY2024, which is 22.90% up from last year.
- As of Q4 2024, Ascentage Pharma Group International's Accounts Payables stood at $12.6 million, which was up 25.22% from $10.1 million recorded in Q4 2023.
- Ascentage Pharma Group International's Accounts Payables' 5-year high stood at $12.6 million during Q4 2024, with a 5-year trough of $10.1 million in Q4 2023.
- In the last 2 years, Ascentage Pharma Group International's Accounts Payables had a median value of $11.3 million in 2023 and averaged $11.3 million.
- Data for Ascentage Pharma Group International's Accounts Payables shows a peak YoY increased of 25.22% (in 2024) over the last 5 years.
- Over the past 2 years, Ascentage Pharma Group International's Accounts Payables (Quarterly) stood at $10.1 million in 2023, then increased by 25.22% to $12.6 million in 2024.
